Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter. | Eur Arch Otorhinolaryngol | 2023 | 35913631 | PubTator, text mining | PubMed |
| Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer. | Laryngoscope | 2023 | 35801573 | PubTator, text mining | PubMed |
| Six Cases of Erythrodermic Pemphigus Foliaceus: A Case Report. | Case Rep Dermatol | 2022 | 36846101 | PubTator, text mining | PubMed |
| MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework. | Front Microbiol | 2022 | 36704547 | PubTator, text mining | PubMed |
| Supraglottic NUT Carcinoma: A Case Report and Literature Review. | Case Rep Oncol | 2022 | 36636674 | PubTator, text mining | PubMed |
DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study. | Transl Lung Cancer Res | 2022 | 36636408 | PubTator, text mining | PubMed |
| Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. | Int J Mol Sci | 2022 | 36613491 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Role of Oncostatin M in the Pathogenesis of Vernal Keratoconjunctivitis: Focus on the Barrier Function of the Epithelium and Interleukin-33 Production by Fibroblasts. | Invest Ophthalmol Vis Sci | 2022 | 36580308 | PubTator, text mining | PubMed |
| Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit. | Front Oncol | 2022 | 36568217 | PubTator, text mining | PubMed |
| Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning? | Front Oncol | 2022 | 36568188 | PubTator, text mining | PubMed |
| Resveratrol against Cervical Cancer: Evidence from In Vitro and In Vivo Studies. | Nutrients | 2022 | 36558430 | PubTator, text mining | PubMed |
| Interaction of Colloidal Gold Nanoparticles with Urine and Saliva Biofluids: An Exploratory Study. | Nanomaterials (Basel) | 2022 | 36558287 | PubTator, text mining | PubMed |
| Primary Squamous Cell Carcinoma of the Liver with Good Response to Carboplatin and 5-Flurouracil: A Case Report. | Medicina (Kaunas) | 2022 | 36557066 | PubTator, text mining | PubMed |
| Gene Expression Linked to Reepithelialization of Human Skin Wounds. | Int J Mol Sci | 2022 | 36555389 | PubTator, text mining | PubMed |
| Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning. | Genes (Basel) | 2022 | 36553569 | PubTator, text mining | PubMed |
| Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma. | Diagnostics (Basel) | 2022 | 36553210 | PubTator, text mining | PubMed |
| Cathepsins Trigger Cell Death and Regulate Radioresistance in Glioblastoma. | Cells | 2022 | 36552871 | PubTator, text mining | PubMed |
| Antioxidant Intervention against Male Infertility: Time to Design Novel Strategies. | Biomedicines | 2022 | 36551814 | PubTator, text mining | PubMed |
| Recent advances in esophageal squamous cell precancerous conditions: A review. | Medicine (Baltimore) | 2022 | 36550838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=19